全文获取类型
收费全文 | 3532篇 |
免费 | 152篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 57篇 |
妇产科学 | 101篇 |
基础医学 | 373篇 |
口腔科学 | 110篇 |
临床医学 | 212篇 |
内科学 | 730篇 |
皮肤病学 | 14篇 |
神经病学 | 333篇 |
特种医学 | 146篇 |
外科学 | 674篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 308篇 |
眼科学 | 32篇 |
药学 | 211篇 |
中国医学 | 3篇 |
肿瘤学 | 349篇 |
出版年
2024年 | 3篇 |
2023年 | 18篇 |
2022年 | 69篇 |
2021年 | 112篇 |
2020年 | 54篇 |
2019年 | 75篇 |
2018年 | 84篇 |
2017年 | 72篇 |
2016年 | 111篇 |
2015年 | 108篇 |
2014年 | 134篇 |
2013年 | 197篇 |
2012年 | 308篇 |
2011年 | 293篇 |
2010年 | 157篇 |
2009年 | 154篇 |
2008年 | 254篇 |
2007年 | 212篇 |
2006年 | 217篇 |
2005年 | 199篇 |
2004年 | 190篇 |
2003年 | 138篇 |
2002年 | 146篇 |
2001年 | 20篇 |
2000年 | 33篇 |
1999年 | 31篇 |
1998年 | 18篇 |
1997年 | 24篇 |
1996年 | 22篇 |
1995年 | 35篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 22篇 |
1991年 | 25篇 |
1990年 | 35篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 8篇 |
1984年 | 2篇 |
1982年 | 5篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1957年 | 2篇 |
1955年 | 2篇 |
1954年 | 2篇 |
1940年 | 1篇 |
排序方式: 共有3714条查询结果,搜索用时 0 毫秒
41.
Gennaro Daniele Clorinda Schettino Laura Arenare Domenico Bilancia Fabio Farinati Piera Federico Stefano Tamberi Gino Crivellari Sandro Barni Raffaella Tortora Francesco Izzo Antonio Frassoldati Luigi Cavanna Claudia Mucciarini Luigi Bolondi Angelo Dinota Filippo Pelizzaro Maria Carmela Piccirillo Piera Gargiulo Massimo Di Maio Ciro Gallo Francesco Perrone Bruno Daniele 《肝癌研究(英文版)》2021,7(7):52-65
Aim: Only patients with good liver function {[Child-Pugh (CP)] A class} were eligible for trials testing sorafenib as first-line treatment of hepatocellular car... 相似文献
42.
Roberto Lorusso Samuel Heuts Federica Jiritano Roberto Scrofani Carlo Antona Guglielmo Actis Dato Paolo Centofanti Sandro Ferrarese Matteo Matteucci Antonio Miceli Mattia Glauber Enrico Vizzardi Sandro Sponga Igor Vendramin Andrea Garatti Carlo de Vincentis Michele De Bonis Silvia Ajello Giovanni Troise Margherita Dalla Tomba Filiberto Serraino 《Interactive Cardiovascular and Thoracic Surgery》2022,35(1)
Open in a separate window OBJECTIVESAlthough the intra-aortic balloon pump (IABP) has been the most widely adopted temporary mechanical support device in cardiac surgical patients, its use has declined. The current study aimed to evaluate the occurrence and predictors of early mortality and complication rates in contemporary cardiac surgery patients supported by an IABP.METHODSA multicentre, retrospective analysis was performed of all consecutive cardiac surgical patients receiving perioperative balloon pump support in 8 centres between January 2010 to December 2019. The primary outcome was early mortality, and secondary outcomes were balloon-associated complications. A multivariable binary logistic regression model was applied to evaluate predictors of the primary outcome.RESULTSThe study cohort consisted of 2615 consecutive patients. The median age was 68 years [25th percentile 61, 75th percentile 75 years], with the majority being male (76.9%), and a mean calculated 30-day mortality risk of 10.0%. Early mortality was 12.7% (n = 333), due to cardiac causes (n = 266), neurological causes (=22), balloon-related causes (n = 5) and other causes (n = 40). A composite end point of all vascular complications occurred in 7.2% of patients, and leg ischaemia was observed in 1.3% of patients. The most important predictors of early mortality were peripheral vascular disease [odds ratio (OR) 1.63], postoperative dialysis requirement (OR 10.40) and vascular complications (OR 2.57).CONCLUSIONSThe use of the perioperative IABP proved to be safe and demonstrated relatively low complication rates, particularly for leg ischaemia. As such, we believe that specialists should not be held back to use this widely available treatment in high-risk cardiac surgical patients when indicated. 相似文献
43.
Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. 总被引:17,自引:0,他引:17
Ehab M Kamel Miriam Thumshirn Kaspar Truninger Marc Schiesser Michael Fried Barbara Padberg Didier Schneiter Sandro J Stoeckli Gustav K von Schulthess Katrin D M Stumpe 《Journal of nuclear medicine》2004,45(11):1804-1810
This study was undertaken to identify the clinical value of incidentally detected lesions (IDLs) in the gastrointestinal tract (GIT) with (18)F-FDG PET/CT. METHODS: The reported database of 3,281 patients who underwent partial-body (18)F-FDG PET/CT scans from April 2001 to September 2003 was reviewed. Patients with incidental (18)F-FDG accumulations in the GIT that were associated with concomitant abnormal soft-tissue density or wall thickening on the native CT were evaluated. Incidental PET/CT findings were correlated with endoscopic and histopathologic results. RESULTS: According to our selection criteria, 98 (3%) of the 3,281 patients had an IDL of the GIT on (18)F-FDG PET/CT. Correlative endoscopic findings were available in 69 (70%) of 98 patients. Of these, 13 patients (19%) were harboring newly occurring cancers of the GIT in addition to preexisting aerodigestive tract tumors (n = 12) and malignant melanoma (n = 1). Twenty-nine (42%) patients were identified with precancerous lesions, such as advanced colonic adenomas (n = 27), Barrett's esophagus (n = 1), and intestinal metaplasia of the gastric mucosa (n = 1). Inflammatory and other benign GIT lesions were detected in 12 (17%) and 6 (8%) patients, respectively. In 9 (13%) patients, PET/CT was false-positive, showing normal findings in subsequent endoscopic examinations. In 20 (28%) of 69 patients, PET/CT findings had a relevant impact on the clinical management. Twenty-nine (30%) of the 98 patients were not subject to a further endoscopic examination because of the extent and nature of the primary tumor (n = 17), loss to follow-up (n = 7), death shortly after PET (n = 3), and patient unwillingness (n = 2). CONCLUSION: Although IDLs of the GIT on (18)F-FDG PET/CT scans are found only in about 3% of cases, they are associated with a substantial risk of an underlying cancerous or precancerous lesion. Early identification of these occult lesions may have a major impact on the patients' management and outcome. 相似文献
44.
45.
Poor-risk metastatic renal cell carcinoma (RCC) includes a subgroup of patients with unfavorable prognosis, according to both the Motzer and Heng criteria. Overall, owing to the poor prognosis of these patients, the approach is still a challenge for the first and subsequent lines of treatment, particularly for rare histologies other than clear cell renal cell carcinoma. In this review, we investigated the present treatment option of poor-risk metastatic RCC. Areas covered are data with first and further line of therapy with mTOR inhibitors and other agents but without cytoreductive nephrectomy or rare histologies. The current data on systemic therapy in poor-risk metastatic RCC maintain temsirolimus as the preferred first-line therapy. New agents targeting immune checkpoints are being developed in clinical trials. 相似文献
46.
47.
Francesco Scolari Elisa Delbarba Domenico Santoro Loreto Gesualdo Antonello Pani Nadia Dallera Laila-Yasmin Mani Marisa Santostefano Sandro Feriozzi Marco Quaglia Giuliano Boscutti Angelo Ferrantelli Carmelita Marcantoni Patrizia Passerini Riccardo Magistroni Federico Alberici Gian Marco Ghiggeri Claudio Ponticelli Pietro Ravani for the RI-CYCLO Investigators 《Journal of the American Society of Nephrology : JASN》2021,32(4):972
48.
49.
Here we describe Hb F-Avellino [Gγ41(C7)Phe?→?Leu; HBG2: c.124?T?>?C], a new hemoglobin (Hb) variant observed in a healthy newborn. The proband’s hemolysate was found to be mildly unstable by the isopropanol test. The occurrence of the variant was assessed by both chromatographic and electrophoretic methods. DNA sequencing analysis of the Gγ gene showed a T to C transition at codon 41 (TTC?>?CTC) corresponding to the Phe?→?Leu substitution. Normal functional properties have been hypothesized. 相似文献
50.